Gavin P Dowling

PARP Inhibitors in Breast Cancer: a Short Communication

Gordon R. Daly, Maen Monketh Alrawashdeh, Jason McGrath et al. · Current Oncology Reports · 2024 · 24 citations · Full text

Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)

Gavin P Dowling, Sinéad Toomey, Philip Bredin et al. · BMC Cancer · 2024 · 17 citations · Full text

Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer ≥ 70 Years Old?

Gordon R. Daly, Gavin P Dowling, Eman Hamza et al. · Clinical Breast Cancer · 2024 · 11 citations · Full text

A bibliometric analysis of HER2-positive breast cancer: 1987–2024

Sherlissa Ali-Thompson, Gordon R. Daly, Gavin P Dowling et al. · Frontiers in Oncology · 2024 · 10 citations · Full text